These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2073116)

  • 1. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental dermatophytosis in guinea pigs.
    Arika T; Yokoo M; Hase T; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2250-3. PubMed ID: 2073116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Trichophyton mentagrophytes activity and percutaneous permeation of butenafine in guinea pigs.
    Arika T; Hase T; Yokoo M
    Antimicrob Agents Chemother; 1993 Feb; 37(2):363-5. PubMed ID: 8452371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butenafine.
    McNeely W; Spencer CM
    Drugs; 1998 Mar; 55(3):405-12; discussion 413. PubMed ID: 9530545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butenafine and superficial mycoses: current status.
    Singal A
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):999-1005. PubMed ID: 18624686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butenafine hydrochloride: for the treatment of interdigital tinea pedis.
    Syed TA; Maibach HI
    Expert Opin Pharmacother; 2000 Mar; 1(3):467-73. PubMed ID: 11249531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of terbinafine in experimental fungal infections of laboratory animals.
    Petranyi G; Meingassner JG; Mieth H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1558-61. PubMed ID: 3435103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Arika T; Yokoo M; Yamaguchi H
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and antifungal activity of butenafine hydrochloride (KP-363), a new benzylamine antifungal agent].
    Maeda T; Takase M; Ishibashi A; Yamamoto T; Sasaki K; Arika T; Yokoo M; Amemiya K
    Yakugaku Zasshi; 1991 Feb; 111(2):126-37. PubMed ID: 2056447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antifungal efficacy in an optimized animal model of Trichophyton mentagrophytes-dermatophytosis.
    Ghannoum MA; Hossain MA; Long L; Mohamed S; Reyes G; Mukherjee PK
    J Chemother; 2004 Apr; 16(2):139-44. PubMed ID: 15216947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model.
    Ghannoum MA; Long L; Pfister WR
    Mycoses; 2009 Jan; 52(1):35-43. PubMed ID: 18498299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two mechanisms of butenafine action in Candida albicans.
    Iwatani W; Arika T; Yamaguchi H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):785-8. PubMed ID: 8494375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antimycotic activity of naftifine.
    Petranyi G; Georgopoulos A; Mieth H
    Antimicrob Agents Chemother; 1981 Mar; 19(3):390-2. PubMed ID: 7247367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs.
    Tatsumi Y; Yokoo M; Arika T; Yamaguchi H
    Antimicrob Agents Chemother; 2001 May; 45(5):1493-9. PubMed ID: 11302816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the growth in vitro of Trichophyton mentagrophytes, Trichophyton erinacei and Microsporum persicolor by miconazole and chlorhexidine.
    Perrins N; Howell SA; Moore M; Bond R
    Vet Dermatol; 2005 Oct; 16(5):330-3. PubMed ID: 16238813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolo[1,2-α][1,4]benzodiazepines show potent in vitro antifungal activity and significant in vivo efficacy in a Microsporum canis dermatitis model in guinea pigs.
    Paulussen C; de Wit K; Boulet G; Cos P; Meerpoel L; Maes L
    J Antimicrob Chemother; 2014 Jun; 69(6):1608-10. PubMed ID: 24535279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of terbinafine compared to lanoconazole and luliconazole in the topical treatment of dermatophytosis in a guinea pig model.
    Ghannoum MA; Long L; Kim HG; Cirino AJ; Miller AR; Mallefet P
    Med Mycol; 2010 May; 48(3):491-7. PubMed ID: 20370362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral itraconazole versus topical bifonazole treatment in experimental dermatophytosis.
    Borgers M; Xhonneux B; Van Cutsem J
    Mycoses; 1993; 36(3-4):105-15. PubMed ID: 8396203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antifungal agent butenafine manifests anti-inflammatory activity in vivo.
    Nahm WK; Orengo I; Rosen T
    J Am Acad Dermatol; 1999 Aug; 41(2 Pt 1):203-6. PubMed ID: 10426889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Butenafine: an update of its use in superficial mycoses.
    Gupta AK
    Skin Therapy Lett; 2002 Sep; 7(7):1-2, 5. PubMed ID: 12432425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.